Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L DeMets

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
The Lancet. Microbe|August 2, 2021
Genomic surveillance to combat COVID-19: challenges and opportunitiesJanet D Robishaw, Scott M Alter, Joshua J Solano, et al.
The American Journal of Medicine|March 15, 2024
Guidance for Healthcare Providers on Newest Guidelines for Over-the-Counter Drug Treatment of Mild Symptoms of COVID-19Gage Collamore, Mark J DiCorcia, Yash Nagpal, et al.
Lancet (London, England)|October 17, 2008
Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trialJohn A Baron, Robert S Sandler, Robert S Bresalier, et al.
The American Journal of Medicine|October 25, 2016
Randomized Trial of Plaque-Identifying Toothpaste: Decreasing Plaque and InflammationKim Fasula, Carla A Evans, Linda Boyd, et al.
Clinical Trials (London, England)|November 11, 2005
Liability issues for data monitoring committee membersDavid L DeMets, Thomas R Fleming, Frank Rockhold, et al.
Controlled Clinical Trials|May 22, 2003
Toward protecting the safety of participants in clinical trialsRobert M Califf, Michael A Morse, Janet Wittes, et al.
Clinical Trials (London, England)|April 1, 2025
Response to Cleland and AnzarJanet Wittes, David L DeMets, KyungMann Kim, et al.
Clinical Trials (London, England)|April 1, 2025
Aspirin in primary prevention: Undue reliance on an uninformative trial led to misinformed clinical guidelinesJanet Wittes, David L DeMets, KyungMann Kim, et al.
JACC. Heart Failure|March 14, 2014
Effect of amlodipine on the survival of patients with severe chronic heart failure due to a nonischemic cardiomyopathy: results of the PRAISE-2 study (prospective randomized amlodipine survival evaluation 2)Milton Packer, Peter Carson, Uri Elkayam, et al.
Circulation. Arrhythmia and Electrophysiology|January 13, 2018
Machine Learning Algorithm Predicts Cardiac Resynchronization Therapy Outcomes: Lessons From the COMPANION TrialMatthew M Kalscheur, Ryan T Kipp, Matthew C Tattersall, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
The Lancet. Microbe|August 2, 2021
Genomic surveillance to combat COVID-19: challenges and opportunitiesJanet D Robishaw, Scott M Alter, Joshua J Solano, et al.
The American Journal of Medicine|March 15, 2024
Guidance for Healthcare Providers on Newest Guidelines for Over-the-Counter Drug Treatment of Mild Symptoms of COVID-19Gage Collamore, Mark J DiCorcia, Yash Nagpal, et al.
Lancet (London, England)|October 17, 2008
Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trialJohn A Baron, Robert S Sandler, Robert S Bresalier, et al.
The American Journal of Medicine|October 25, 2016
Randomized Trial of Plaque-Identifying Toothpaste: Decreasing Plaque and InflammationKim Fasula, Carla A Evans, Linda Boyd, et al.
Clinical Trials (London, England)|November 11, 2005
Liability issues for data monitoring committee membersDavid L DeMets, Thomas R Fleming, Frank Rockhold, et al.
Controlled Clinical Trials|May 22, 2003
Toward protecting the safety of participants in clinical trialsRobert M Califf, Michael A Morse, Janet Wittes, et al.
Clinical Trials (London, England)|April 1, 2025
Response to Cleland and AnzarJanet Wittes, David L DeMets, KyungMann Kim, et al.
Clinical Trials (London, England)|April 1, 2025
Aspirin in primary prevention: Undue reliance on an uninformative trial led to misinformed clinical guidelinesJanet Wittes, David L DeMets, KyungMann Kim, et al.
JACC. Heart Failure|March 14, 2014
Effect of amlodipine on the survival of patients with severe chronic heart failure due to a nonischemic cardiomyopathy: results of the PRAISE-2 study (prospective randomized amlodipine survival evaluation 2)Milton Packer, Peter Carson, Uri Elkayam, et al.
Circulation. Arrhythmia and Electrophysiology|January 13, 2018
Machine Learning Algorithm Predicts Cardiac Resynchronization Therapy Outcomes: Lessons From the COMPANION TrialMatthew M Kalscheur, Ryan T Kipp, Matthew C Tattersall, et al.
Pageof 10